MMM — Medicare/Medicaid
Policies related to the ASP calculation in Medicare Part B Promoting a resilient pharmaceutical supply chain Policies related to serial patent litigation under the Hatch-Waxman Act. Issues related to increasing access to generic and biosimilar medications
- MICHAEL BARNARD
- KATHLEEN CALLANAN — covered position: Senior Legislative Assistant, Representative Mike Ross [new]
- JONATHAN KIMBALL
Government entities lobbied: Commerce, Dept of (DOC); Defense, Dept of (DOD); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE